Stock ZBH ZIMMER BIOMET HOLDINGS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Zimmer Biomet Holdings, Inc. Swiss Exchange

Equities

ZBH

US98956P1021

Market Closed - Swiss Exchange
Other stock markets
 08:17:28 24/04/2024 BST 		5-day change 1st Jan Change
113 CHF +15.31% Intraday chart for Zimmer Biomet Holdings, Inc. -.--% +15.31%
05-03 Raymond James Adjusts Price Target on Zimmer Biomet Holdings to $138 From $142 MT
05-03 UBS Adjusts Price Target on Zimmer Biomet Holdings to $112 From $109, Maintains Sell Rating MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Zimmer Biomet Announces 2024 Investor Day
PR
4 Stocks to Watch in the Booming Regenerative Medicine Market
AQ
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2024
PR
Zimmer Biomet Announces Quarterly Dividend for Second Quarter of 2024, Payable on or About July 31, 2024
CI
Zimmer Biomet Publishes 2023 Sustainability Report
PR
Raymond James Adjusts Price Target on Zimmer Biomet Holdings to $138 From $142
MT
UBS Adjusts Price Target on Zimmer Biomet Holdings to $112 From $109, Maintains Sell Rating
MT
Truist Adjusts Zimmer Biomet Holdings' PT to $130 From $137, Keeps Hold Rating
MT
Bernstein Adjusts Price Target on Zimmer Biomet to $133 From $132
MT
Jefferies Adjusts Price Target on Zimmer Biomet to $135 From $136
MT
Citigroup Adjusts Price Target on Zimmer Biomet to $134 From $140
MT
Morgan Stanley Adjusts Price Target on Zimmer Biomet to $130 From $135
MT
Jefferies Adjusts Zimmer Biomet Price Target to $135 From $136
MT
Citigroup Adjusts Zimmer Biomet Price Target to $134 From $140
MT
Morgan Stanley Adjusts Zimmer Biomet Price Target to $130 From $135
MT
Oppenheimer Adjusts Price Target on Zimmer Biomet Holdings to $155 From $150
MT
BTIG Adjusts Price Target on Zimmer Biomet to $139 From $138, Keeps Buy Rating
MT
Transcript : Zimmer Biomet Holdings, Inc., Q1 2024 Earnings Call, May 02, 2024
Zimmer Biomet beats Q1 profit estimates on robust demand for knee, hip devices
RE
Zimmer Biomet Holdings Q1 Adjusted Earnings, Net Sales Rise; 2024 Outlook Reiterated
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ZBH Stock
  4. ZBH Stock
  5. News Zimmer Biomet Holdings, Inc.